logo-loader
Genedrive PLC

Riccardo Lowi discusses Genedrive Plc

Riccardo Lowi, analyst at Capital Network on the launch preparation of Genedrive® HCV test with partner Sysmex on track, expect sales to start coming through in CY2018.

Quick facts: Genedrive PLC

Price: £0.18

Market: AIM
Market Cap: £6.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Genedrive PLC named herein, including the promotion by the Company of Genedrive PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Genedrive PLC optimistic on the long-term opportunity for its HCV test

Genedrive PLC (LON:GDR) CEO David Budd tells Proactive London's Andrew Scott he remains confident the World Health Organisation will pre-qualify its HCV ID hepatitis C test in the near term despite some delays to the clinical trial. He adds that the development of an antibiotic-induced...

on 12/7/19

2 min read